Transformational change: nurses substituting for ophthalmologists for intravitreal injections - a quality-improvement report
- PMID: 24790403
- PMCID: PMC3998867
- DOI: 10.2147/OPTH.S59982
Transformational change: nurses substituting for ophthalmologists for intravitreal injections - a quality-improvement report
Abstract
Background: The dramatic increase in need for anti-vascular endothelial growth factor (anti-VEGF) intravitreal therapy in the treatment of retinal disease and the absence of an equivalent increase in ophthalmologists to undertake such intravitreal injections created a patient-safety risk. Timing of intravitreal therapy (IVT) is critical to prevent vision loss and local clinics lacked capacity to treat patients appropriately. We aimed to improve capacity for IVT by nurse injections.
Materials and methods: A multidisciplinary prospective service-improvement process was undertaken at two adjacent general hospitals in the northwest of England. IVT injections by nurses were a principal component of solution development. After we had obtained appropriate institutional approval, experienced ophthalmic nurses were trained, supervised, and assessed to undertake IVT. Ophthalmologists directly supervised the first 200 injections, and a retina specialist was always on site.
Results: Nurses undertook 3,355 intravitreal injections between June 2012 and November 2013, with minor adverse events (0.3% subconjunctival hemorrhage and corneal abrasion). There were no patient complaints at either hospital.
Conclusion: Experienced ophthalmic nurses quickly learned how to perform such injections safely. IVT by nurses was well accepted by patients and staff. Hospital A trained three nurses sequentially for improved flexibility in scheduling. Novel use of appropriately trained non-medical staff can improve efficiency and access in an overburdened service with time-sensitive disease. Retinal assessment was undertaken by ophthalmologists only. Improved access to IVT is important, as treatment with anti-VEGF therapy reduces blindness at population levels.
Keywords: age-related macular degeneration; extended roles; nurse; ophthalmology; retina; transformation.
References
-
- Bressler NM. Age-related macular degeneration is the leading cause of blindness…. JAMA. 2004;291:1900–1901. - PubMed
-
- Wong TY, Chakravarthy U, Klein R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008;115:116–126. - PubMed
-
- National Institute for Health and Clinical Excellence . Ranibizumab and Pegaptanib for the Treatment of Age-Related Macular Degeneration. London: NICE; 2008. [Accessed February 12, 2014]. Available from: http://www.nice.org.uk/nicemedia/live/12057/41719/41719.pdf.
-
- National Institute for Health and Care Excellence . Ranibizumab for Diabetic Macular Odema (Rapid Review of Technology Appraisal Guidance 237) London: NICE; 2013. [Accessed February 12, 2014]. Available from: http://www.nice.org.uk/nicemedia/live/14082/62873/62873.pdf.
-
- National Institute for Health and Care Excellence . Ranibizumab for Treating Visual Impairment Caused by Macular Oedema Secondary to Retinal Vein Occlusion. London: NICE; 2013. [Accessed February 12, 2014]. Available from: http://www.nice.org.uk/nicemedia/live/14169/63851/63851.pdf.
LinkOut - more resources
Full Text Sources
Other Literature Sources